In Nanjing, Jiangsu, the pharmaceutical representative Xiao Wei has long been responsible for the promotion of a certain heart disease drug in key hospitals. Now, like millions of medical representatives across the country, he is facing the choice of going and staying, which is the biggest crisis since he started his career.
The crisis first came from the state's rectification of the "drug generation." At the beginning of this year, the State Council issued a document requesting medical representatives not to undertake the task of drug sales. This means that the unspoken rules of “golden sales†in the industry have been banned, and the living space of “pharmaceutical generation†has become smaller.
However, the truly deadly crisis comes from the Internet of Things, and it is likely to make Xiao Wei's career completely history.
In Wuxi High-tech Zone on the north shore of Taihu Lake, AstraZeneca, an international pharmaceutical company, has set up a commercial innovation center here. The most striking thing here is not all kinds of specific drugs for treating tumors, but a dynamically updated data map, as well as a treatment plan for the disease that is accurate to the minute and fine to micron.
Like Xiao Wei, who graduated from the medical profession, Lu Yanbin, manager of the AstraZeneca Wuxi Respiratory Division, feels that his career space is very broad. The person in charge of an atomized pharmaceutical company came over and hoped to incorporate his products into AstraZeneca's sales plan. Lu Yanbin said that in the innovation center, someone will visit or seek cooperation every three to five.
“Home sales will be replaced by big data sales.†Lu Yanbin pointed to a large screen in the exhibition hall. On the screen is a map of Jiangsu atomization data, which city, which area, which hospital has a number of atomization equipment at a glance. The core technology of this picture is just a small chip mounted on the atomizer. The data fed back from the chip can see the operation status of each atomizer. With data analysis, the demand and consumption of atomized pharmaceutical equipment can be accurately calculated.
With big data, the drug dosage and equipment model can also be customized in combination with the characteristics of the hospital. The sales have also been transformed from piecemeal sales to packaged precision push. This makes Xiao Wei feel very much, the traditional "pharmaceutical" type of sales, data collection is commonly known as "the unified side", mainly to count the doctor's medication, feedback to the production enterprises, and carry out targeted public relations. The Internet of Things has eliminated the “unificationâ€, allowing demand information to be directly fed back to the company and maintaining a stable sales channel.
Not only has the way of selling drugs changed, but the process of seeing a doctor has also changed. Shortening the crowing time (from the entrance to the hospital to the time when the vasodilator balloon is extended) is the key to reducing the death of a sudden cardiovascular disease. The National Health and Family Planning Commission Hospital Management Research Institute and other institutions are relying on the Internet of Things to design a set of rapid diagnosis and treatment procedures for cardiovascular disease - "China Chest Pain Center". In the place where the chest pain center was established in Wuxi and other places, the Internet of Things started to rush for the patients from the ambulance: the backstage recommended the fastest driving route for the driver, and the ECG was returned within 10 minutes. After the diagnosis of myocardial infarction, the CCU can be bypassed. The catheter is opened to occlude the blood vessel.
Prostate cancer, digestive tract tumors, metabolic diseases, etc., also rely on the Internet of Things to form a new diagnosis and treatment program. Li Wei, a doctor at the First Hospital of Nanjing, felt the changes brought about by the new treatment plan. "These programs break the division of the traditional departments, so that the medical staff around a disease effectively together, to more efficiently solve the problem." She said that the state in promoting the DRGs, the medical process integration by disease treatment on the basis of, It is the latest change in the medical system's change. The unexpected thing is that the catalyst for change turns out to be the Internet of Things.
At the end of 2016, the total number of health workers in China reached 11.173 million, an increase of 479,000 over the previous year. However, medical resources remained tight, with an average of less than three doctors per thousand patients. "In this context, can you imagine? The hospital is full of people's troubles, I am afraid I can't see it." Zhao Yang, deputy director of the Third People's Hospital of Wuxi, said that relying on the new process supported by the Internet of Things, registration, testing on the ambulance It can be done, and when the car arrives at the hospital, the doctor has determined the treatment plan through the information returned in real time. The Internet of Things is infiltrating into all aspects of surgery, nursing, medicine, etc. It is no longer a hassle to go to the hospital to see a doctor.
After all, it is still inconvenient to go to the hospital. Can you look at the disease without going out? The rapid spread of family medical equipment based on the Internet of Things allows people to seek medical advice without leaving home. A “Medical Information Platform†was launched at Wuxi People’s Hospital. Song Hongjian, general manager of Jiangsu Mandala Software Co., Ltd., said that the platform collects vital signs such as blood sugar, blood pressure and blood oxygen from wearable devices and monitors patients in real time. The condition forms a health assessment report, and once the vital signs are abnormal, an early warning is automatically issued.
Fang Lanzhen, a 69-year-old Wuxi citizen, recently felt unwell, measured blood pressure and blood sugar at home, and uploaded the data to the family doctor Pan Mengdi's mobile phone in real time. Pan Mengdi can also see the results of the elderly seeing doctors in various hospitals throughout the city. He will guide the elderly to take medication and adjust the diet at any time according to the situation. “I am now a family doctor in the community of 50 patients with high blood pressure and high blood sugar and chronic diseases. If the blood pressure and blood sugar level of the patient are high every day, the mobile phone will alarm me,†Pan Mengdi said.
In Wuxi, about 3,000 chronically diseased residents with unstable conditions have access to the smart medical network in 9 communities in 9 streets. In the future, this network may cover all citizens. Since everyone is online, more health care reforms can be more easily promoted. Han Xiaofeng, vice chairman of the Wuxi CPPCC, said that the local medical data center will be built to fully integrate all medical information such as personal health records, diagnostic records, doctors' consultation time, and drug reserves in various medical institutions in Wuxi. In the future, hospitals at all levels in this city will perform their duties under the cooperation of the Internet of Things, and the reform of the graded diagnosis and treatment system is also expected to achieve substantial progress. (Economic Information Daily)
Functional oligosaccharides refer to oligosaccharides that are difficult or impossible to be digested and absorbed by the human body and have special physiological effects on the human body. Its sweetness is generally only 30-50% of that of sucrose, and it has physiological functions such as low-calorie, anti-caries, prevention and treatment of diabetes, and improvement of intestinal colony structure. Due to the special physiological functions of functional oligosaccharides, it becomes a nutrient and health care product. A new generation of food-effect raw materials that integrate diet and therapy. It is a new functional sugar source that replaces sucrose and has a wide range of uses and application prospects. Common functional oligosaccharides include: xylo-oligosaccharides, fructooligosaccharides, galacto-oligosaccharides, isomaltose, raffinose and so on.
XOS, GOS, FOS, IMO, Raffinose, oligosaccharide
Xi'an Gawen Biotechnology Co., Ltd , https://www.ahualynbios.com